Global Research-Grade Genetic Testing Market Growth (Status and Outlook) 2023-2029

Global Research-Grade Genetic Testing Market Growth (Status and Outlook) 2023-2029

The global Research-Grade Genetic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Research-Grade Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Research-Grade Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Research-Grade Genetic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Research-Grade Genetic Testing players cover Thermo Fisher Scientific, Oxford Nanopore Technologies, Illumina, Ambry Genetics, Qiagen, PerkinElmer, BGI Group, Novogene and DaAn Gene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Research-grade genetic testing refers to basic research and drug development by scientists in genetics, mainly for researchers and research institutions.

LPI (LP Information)' newest research report, the “Research-Grade Genetic Testing Industry Forecast” looks at past sales and reviews total world Research-Grade Genetic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Research-Grade Genetic Testing sales for 2023 through 2029. With Research-Grade Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Research-Grade Genetic Testing industry.

This Insight Report provides a comprehensive analysis of the global Research-Grade Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Research-Grade Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Research-Grade Genetic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Research-Grade Genetic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Research-Grade Genetic Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Research-Grade Genetic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Whole Exome Sequencing (WES)
Whole Genome Sequencing (WGS)
Genome-Wide Association Studies (GWAS)
Others

Segmentation by application
Complex Disease
Rare Disease
Genetic Diversity
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Oxford Nanopore Technologies
Illumina
Ambry Genetics
Qiagen
PerkinElmer
BGI Group
Novogene
DaAn Gene

Please note: The report will take approximately 2 business days to prepare and deliver.